随着国药控股、上海医药、华润医药三大医药流通巨头相继发布2024年业绩报告,医药流通行业寡头化趋势再度成为焦点。数据显示,2024年三大巨头营收总额突破千亿元,但净利润表现分化明显。国药控股以5845亿元营收稳居龙头,归母净利润为70.50亿元,同比下降22.14%。紧随其后的是上海医药,营业收入为2752.51亿元,归母净利润45.53亿元,同比增长20.82%。华润医药实现营收2576.73...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.